Literature DB >> 22668754

Polymorphisms in the transcription factor NRF2 and forearm vasodilator responses in humans.

Ewa D Marczak1, Jacqui Marzec, Darryl C Zeldin, Steven R Kleeberger, Nancy J Brown, Mias Pretorius, Craig R Lee.   

Abstract

OBJECTIVE: Oxidative stress is integral to the development of endothelial dysfunction and cardiovascular disease. As NRF2 is a key transcription factor in antioxidant defense, we aimed to determine whether polymorphisms within the promoter region of the gene encoding NRF2 (NFE2L2) would significantly modify vasodilator responses in humans.
METHODS: Associations between the -653A/G (rs35652124), -651G/A (rs6706649), and -617C/A (rs6721961) polymorphisms within the NFE2L2 promoter and vascular function were evaluated in healthy African-American (n=64) and white (n=184) individuals. Forearm blood flow (FBF) was measured by strain-gauge venous occlusion plethysmography at baseline and in response to incremental doses of bradykinin or sodium nitroprusside. Forearm vascular resistance (FVR) was calculated as the mean arterial pressure/FBF.
RESULTS: In African Americans, -653G variant allele carriers had significantly lower FBF and higher FVR under basal conditions as well as in response to bradykinin or sodium nitroprusside compared with wild-type individuals (P<0.05 for each comparison). In whites, although no significant associations were observed with the -653A/G genotype, -617A variant allele carriers had significantly higher FVR at baseline and in response to bradykinin or sodium nitroprusside compared with wild-type individuals (P<0.05 for each comparison). The -651G/A polymorphism was not associated with vasodilator responses in either racial group.
CONCLUSION: Polymorphisms within the NFE2L2 promoter were associated with impaired forearm vasodilator responses in an endothelial-independent manner, suggesting an important role of NRF2 in the regulation of vascular function in humans.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22668754      PMCID: PMC3599320          DOI: 10.1097/FPC.0b013e32835516e5

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN: 1744-6872            Impact factor:   2.089


  27 in total

Review 1.  The evolution of transcriptional regulation in eukaryotes.

Authors:  Gregory A Wray; Matthew W Hahn; Ehab Abouheif; James P Balhoff; Margaret Pizer; Matthew V Rockman; Laura A Romano
Journal:  Mol Biol Evol       Date:  2003-05-30       Impact factor: 16.240

2.  Candidate gene association analysis for a quantitative trait, using parent-offspring trios.

Authors:  W James Gauderman
Journal:  Genet Epidemiol       Date:  2003-12       Impact factor: 2.135

3.  Statistical significance for genomewide studies.

Authors:  John D Storey; Robert Tibshirani
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-25       Impact factor: 11.205

4.  Responses of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment. Possible role of early coronary atherosclerosis.

Authors:  H Yasue; K Matsuyama; K Matsuyama; K Okumura; Y Morikami; H Ogawa
Journal:  Circulation       Date:  1990-02       Impact factor: 29.690

5.  Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease.

Authors:  V Schächinger; M B Britten; A M Zeiher
Journal:  Circulation       Date:  2000-04-25       Impact factor: 29.690

6.  Vasodilation in black Americans: attenuated nitric oxide-mediated responses.

Authors:  C M Stein; C C Lang; R Nelson; M Brown; A J Wood
Journal:  Clin Pharmacol Ther       Date:  1997-10       Impact factor: 6.875

7.  Effect of NFE2L2 genetic polymorphism on the association between oral estrogen therapy and the risk of venous thromboembolism in postmenopausal women.

Authors:  J Bouligand; O Cabaret; M Canonico; C Verstuyft; L Dubert; L Becquemont; A Guiochon-Mantel; P Y Scarabin
Journal:  Clin Pharmacol Ther       Date:  2010-11-24       Impact factor: 6.875

8.  Deficiency of the Nrf1 and Nrf2 transcription factors results in early embryonic lethality and severe oxidative stress.

Authors:  Laura Leung; Mandy Kwong; Stephen Hou; Candy Lee; Jefferson Y Chan
Journal:  J Biol Chem       Date:  2003-09-10       Impact factor: 5.157

9.  Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region.

Authors:  P Moi; K Chan; I Asunis; A Cao; Y W Kan
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

10.  Race-specific differences in endothelial function: predisposition of African Americans to vascular diseases.

Authors:  Leszek Kalinowski; Iwona T Dobrucki; Tadeusz Malinski
Journal:  Circulation       Date:  2004-05-24       Impact factor: 29.690

View more
  23 in total

1.  NRF2 activation with Protandim attenuates salt-induced vascular dysfunction and microvascular rarefaction.

Authors:  Jessica R C Priestley; Katie E Fink; Joe M McCord; Julian H Lombard
Journal:  Microcirculation       Date:  2019-06-19       Impact factor: 2.628

Review 2.  Remote ischaemic preconditioning for coronary artery bypass grafting (with or without valve surgery).

Authors:  Carina Benstoem; Christian Stoppe; Oliver J Liakopoulos; Julia Ney; Dirk Hasenclever; Patrick Meybohm; Andreas Goetzenich
Journal:  Cochrane Database Syst Rev       Date:  2017-05-05

Review 3.  Functional polymorphisms in Nrf2: implications for human disease.

Authors:  Hye-Youn Cho; Jacqui Marzec; Steven R Kleeberger
Journal:  Free Radic Biol Med       Date:  2015-06-25       Impact factor: 7.376

4.  Promoter region variation in NFE2L2 influences susceptibility to ototoxicity in patients exposed to high cumulative doses of cisplatin.

Authors:  T F Spracklen; A A Vorster; L Ramma; S Dalvie; R S Ramesar
Journal:  Pharmacogenomics J       Date:  2016-07-26       Impact factor: 3.550

Review 5.  Molecular basis of electrophilic and oxidative defense: promises and perils of Nrf2.

Authors:  Qiang Ma; Xiaoqing He
Journal:  Pharmacol Rev       Date:  2012-09-10       Impact factor: 25.468

6.  Transcription factor NRF2 regulates miR-1 and miR-206 to drive tumorigenesis.

Authors:  Anju Singh; Christine Happel; Soumen K Manna; George Acquaah-Mensah; Julian Carrerero; Sarvesh Kumar; Poonam Nasipuri; Kristopher W Krausz; Nobunao Wakabayashi; Ruby Dewi; Laszlo G Boros; Frank J Gonzalez; Edward Gabrielson; Kwok K Wong; Geoffrey Girnun; Shyam Biswal
Journal:  J Clin Invest       Date:  2013-06-10       Impact factor: 14.808

7.  A Preliminary Study on Racial Differences in HMOX1, NFE2L2, and TGFβ1 Gene Polymorphisms and Radiation-Induced Late Normal Tissue Toxicity.

Authors:  Asim Alam; Nitai D Mukhopadhyay; Yi Ning; Leonid B Reshko; Robert J G Cardnell; Omair Alam; Christopher S Rabender; Vasily A Yakovlev; Linda Walker; Mitchell S Anscher; Ross B Mikkelsen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-06-06       Impact factor: 7.038

8.  The NRF2 knockout rat: a new animal model to study endothelial dysfunction, oxidant stress, and microvascular rarefaction.

Authors:  Jessica R C Priestley; Katie E Kautenburg; Marc C Casati; Bradley T Endres; Aron M Geurts; Julian H Lombard
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-12-04       Impact factor: 4.733

9.  Regulatory nexus of synthesis and degradation deciphers cellular Nrf2 expression levels.

Authors:  Takafumi Suzuki; Tatsuhiro Shibata; Kai Takaya; Kouya Shiraishi; Takashi Kohno; Hideo Kunitoh; Koji Tsuta; Koh Furuta; Koichi Goto; Fumie Hosoda; Hiromi Sakamoto; Hozumi Motohashi; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2013-04-09       Impact factor: 4.272

Review 10.  Activation of Nrf2 signaling by natural products-can it alleviate diabetes?

Authors:  Manuel Matzinger; Katrin Fischhuber; Elke H Heiss
Journal:  Biotechnol Adv       Date:  2017-12-28       Impact factor: 14.227

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.